Kuyler Doyle, PhD MBA
Steering Committee Member
Kuyler currently serves as Head of Discovery Strategy and New Product Planning at ProQR Therapeutics, helping to build a portfolio that optimally connects the emerging RNA editing modality with unmet patient needs to deliver value across stakeholders. Kuyler previously led the New Product Planning & Insights function at LEO Pharma building asset, portfolio, and therapeutic area strategies. Prior to LEO, Kuyler spent ten years at UCB Pharma, first as a Medical Science Liaison supporting the US neurology business before moving to HQ in Brussels to work in New Product Planning and then as a development program leader in R&D. Before UCB, Kuyler worked at Campbell Alliance as a Consultant in the biopharma industry. Kuyler holds a PhD in immunology from the Baylor College of Medicine (Houston, Texas) and an MBA from the University of Houston C.T. Bauer College of Business.